For example, the APOBEC3-induced FGFR3 S249C mutation—the most common FGFR3 mutation in bladder cancer—causes constitutive activation of the encoded growth factor receptor to promote cell proliferation [127, 128]. This evidence concerns the gene FGFR3 and urinary bladder cancer.